Libtayo gained FDA approval as the first immunotherapy for high-risk cutaneous squamous cell carcinoma, promising improved outcomes post-surgery and radiation.

Back surgeries to address age-related pain in older adults aren’t just risky, they're expensive too, according to a recent study from the Lown Institute.

Providing support and care for adults with schizophrenia can mean a significant personal and financial burden for family members.

The PIVOT-006 trial is part of a larger national effort to evaluate cretostimogene’s safety and effectiveness in bladder cancer.

Although neuroendocrine tumors of the digestive system have been studied, far less is known about those that develop in the lungs, even as their incidence appears to be on the rise.

Jascayd targets the enzyme PDE4B, which plays a role in the inflammatory process. The new therapy is able to affect both fibrosis and the immune system. It will be available in the next few weeks.

The CDC updates vaccine schedules, emphasizing personalized decision-making for COVID-19 shots and recommending standalone chickenpox vaccines for toddlers.

In this interview, Steven Buslovich, M.D., CMD, MS, CMO of Senior Care at PointClickCare describes AI’s role in care transitions within healthcare systems and how AI can reduce readmission rates.

Medicare beneficiaries face confusion during the Annual Enrollment Period, with significant plan changes ahead for 2026. Understanding options is crucial.

An engineered CD40 antibody that can bind to a specific immune receptor and directly injected into tumors has demonstrated in a phase 1 trial that it can trigger a systemic immune response.

Older adults living with HIV face higher rates of opioid prescribing and opioid use disorder than their HIV-negative peers, according to new research from Rutgers University.

Researchers say ophthalmologists and optometrists were motivated, at least in part, to use the sutureless grafts for dry eye disease by the profit margin they make on devices.

Researchers in one study found that semaglutide may indirectly improve adherence to antipsychotic therapy for those with schizophrenia and lower expensive acute episodes by preventing weight gain and increasing physical health.

Zoryve cream gains FDA approval for treating mild to moderate atopic dermatitis in young children, offering a safe, steroid-free solution.

Repatha is now available for a monthly cash price of $239, through AmgenNow and GoodRx.

The differing regulation of key fibrotic pathways suggest that idiopathic pulmonary fibrosis involves dysregulation rather than just a speeded-up aging process.

Three researchers have been awarded the Nobel Prize in Physiology or Medicine 2025 for the discovery of regulatory T cells, the FOXP3 gene mutation and the role they play within autoimmune diseases.

Here’s what you missed this week on Managed Healthcare Executive.

A new study confirms ICD-10 code L80's high accuracy in identifying vitiligo, especially when combined with treatment data, enhancing clinical research.

The Chinorec trial reveals that combining Yervoy and Opdivo with chemoradiotherapy is safe for rectal cancer, though response rates remain unchanged.

Expedited regulatory paths transform colorectal cancer treatment, enhancing access but creating challenges in clinical evidence and payer decisions.

The exact cause of amyotrophic lateral sclerosis (ALS) has long remained a mystery, but new research demonstrates that there is an autoimmune component to the disease.

Site neutrality payment, innovations in care delivery and value-based pricing of drugs could at least help to moderate the huge growth in expenditures.